Nature’s Bounty names chief customer officer
Nature’s Bounty on Tuesday named Bob Goode chief customer officer.
“I am excited to have Bob on board, and am confident that the insight, leadership and unyielding determination he brings to our team will take our customer partnerships to the next level,” said Paul Sturman, president and CEO Nature’s Bounty.
Goode succeeds Andrew Archambault, who last week joined Keurig Green Mountain as senior vice president of U.S. commercial leadership after three years with Nature’s Bounty.
“I am thrilled to join The Nature’s Bounty Co., whose commitment to quality and innovation is unwavering, but who also leverages consumer insights and shopper information to bring creative and impactful customer marketing partnerships to the table,” Goode said.
Goode is well-known for his merchandising creativity, cross-functional collaboration, delivery of exceptional results and strong relationships, the Ronkonkoma-N.Y.-based manufacturer stated.
The 30-year consumer health veteran comes to Nature’s Bounty from Johnson & Johnson Consumer, where he was global vice president, customer development. He has extensive experience across the spectrum of Nature’s Bounty’s customer base.
Goode began his career in sales at Warner Lambert, and held increasingly senior management positions both there and subsequently with Pfizer and J&J Consumer. Goode also spent time as senior vice president in the luxury company LVMH (Louis Vuitton Moet Hennessey Watch & Jewelry Group).
A Huge win for Natures Bounty and the combo of Sturman and Goode will rock that space. All the best and congrats to Bob as the CCO .
New Ocean pioneers employer wellness solution
Former Walgreens executive Hal Rosenbluth helped unveil a new way for companies to help employees stay healthy through a platform launched by Conshohocken, Pa.-based New Ocean on Tuesday.
Utlizing the Voyage app, the new platform combines behavior change science with each user’s personal health story. The result is the first tool that can help employees make meaningful improvements in health and wellness at a much lower cost.
“Health isn’t a perk—it’s a necessity. And your people are your company’s most precious asset.”
New Ocean plans to offer this system to companies and health plans with a population of more than 250,000 for 90 cents per member or employee per month. For companies under 250,000, the cost will be $2 per employee per month. According to New Ocean, a health plan with 2 million members will realize savings ranging between $47 million and $175 million over two years.
Today, companies spend as much as $8.40 per person per month on tools to promote wellness, yet most people have no idea that their company offers a health and wellbeing program. “It’s a huge waste of money,” Rosenbluth said. “Many companies have been looking at these health and wellness solutions as just another ‘perk’ to offer, and that has to end. Health isn’t a perk—it’s a necessity. And your people are your company’s most precious asset. Launching New Ocean is about fixing the entire ecosystem of employee wellness: offering a revolutionary product at a revolutionary price.”
The platform begins with input from New Ocean’s private health assessment which lets users set personalized goals and earn and redeem rewards which are completely configurable to a company’s culture and budget. The Voyage can track sleep, can help smokers quit and can monitor nutrition, exercise or personal finances. It’s the only product of its kind to offer a robust Chronic Condition Management suite as part of its core platform with the release of Asthma 2.0 and Diabetes 2.0 completely reimagined, gamified and built around rewards.
New Ocean has choreographed a series of programs scheduled to debut in the coming months rounding out a suite of condition management including COPD and hypertension coming in February, followed by high cholesterol, heart disease (angina, post heart attack support, atrial fibrillation, heart failure), anxiety, depression, diabetes prevention and weight management.
No comments found
CDC: Flu season far from over
It’s not the worst flu season in the past decade, the Centers for Disease Control and Prevention shared during a press conference Friday morning. But it’s pretty close and it’s far from over.
“We are currently in the midst of a very active flu season with much of the country experiencing widespread and intense flu activity,” CDC director Brenda Fitzgerald shared with reporters. “So far this season, influenza A-H3N2 has been the most common form of influenza. These viruses are often linked to more severe illness, especially among children and people age 65 and older. When H3 viruses are predominant, we tend to have a worse flu season with more hospitalizations and more death. While our surveillance systems show that nationally, the flu season may be peaking now, we know from past experience that it will take many more weeks for flu activity to truly slow down.”
The CDC is highly recommending people get their flu shot despite any public consternation that this year’s flu shot isn’t a good defense against this year’s virus. The vaccine effectiveness against the predominant H3N2 strain has been reported in the low 30 percentile range.
“We also continue to recommend the flu vaccine. While our flu vaccines are far from perfect, they are the best way to prevent getting sick from the flu and it is not too late to get one,” Fitzgerald said. “As of this last month, manufacturers reported they shipped more than 151 million doses of flu vaccine, so it should be readily available.”
“This is the first year that we’ve had the entire continental U.S. be the same color on the graph, meaning that there is widespread activity in all of the continental U.S. at this point,” added Dan Jernigan, director of the Influenza Division of the National Center for Immunization and Respiratory Diseases. “The season has started early and is probably peaking right about now,” he said. “It’s looking a lot like the activity from 2014/2015 and 2012/2013. Both of those seasons were seasons where the strain H3N2 was the predominant strain. That’s a strain that is going to be associated with more cases, more hospitalizations and death. In terms of the numbers, we are having a slight increase this week. We’re up at 5.8% [of all patient visits attributed to the flu], which is a slight increase from last week. It’s not quite as high as the 6% that was seen in 2014/2015, but still early season peaking now.”
Over the last 13 years, there have only been two seasons where the CDC has characterized the flu season as “high severity.” The first was 2003/2004. The other was 2014/2015.
“Both of those were H3N2 predominant years. Whether we will reach that level this year we don’t know,” Jernigan said. “If you look at the timing of the season, even if we have hit the top of the curve or the peak of seasonal activity, it still means we have a lot more flu to go. We’re currently in the seventh [week] right now, and in the past, if you look at seasons like the one we’re having, there’s at least 11 to 13 more weeks of influenza to go. In addition, there are also other strains of influenza that are still to be a major cause of disease. [For example], B viruses will be showing later in the season, [which is] another reason why to go ahead and get vaccinated now if you have not gotten vaccinated.”
No comments found